Aristotle University of Thessaloniki-ko ikertzaileekin lankidetzan egindako argitalpenak (18)

2024

  1. IRON: A retrospective international multicenter study on robotic versus laparoscopic versus open approach in gallbladder cancer

    Surgery (United States), Vol. 176, Núm. 4, pp. 1008-1015

2023

  1. Treatment and long-term outcome in primary nephrogenic diabetes insipidus

    Nephrology Dialysis Transplantation, Vol. 38, Núm. 10, pp. 2120-2130

2021

  1. Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe

    ERJ Open Research, Vol. 7, Núm. 4

  2. Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020

    Journal of Cystic Fibrosis, Vol. 20, Núm. 4, pp. 566-577

  3. Survival estimates in European cystic fibrosis patients and the impact of socioeconomic factors: a retrospective registry cohort study

    European Respiratory Journal, Vol. 58, Núm. 3

2020

  1. Changing epidemiology of the respiratory bacteriology of patients with cystic fibrosis–data from the European cystic fibrosis society patient registry

    Journal of Cystic Fibrosis, Vol. 19, Núm. 3, pp. 376-383

  2. Errare humanum est, sed in errare perseverare diabolicum: methodological errors in the assessment of the relationship between I-131 therapy and possible increases in the incidence of malignancies

    European Journal of Nuclear Medicine and Molecular Imaging

2017

  1. A web-based collection of genotype-phenotype associations in hereditary recurrent fevers from the Eurofever registry

    Orphanet Journal of Rare Diseases, Vol. 12, Núm. 1

  2. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: A systematic analysis for the Global Burden of Disease Study 2016

    The Lancet, Vol. 390, Núm. 10100, pp. 1084-1150

2015

  1. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013

    The Lancet, Vol. 385, Núm. 9963, pp. 117-171

  2. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013

    The Lancet, Vol. 386, Núm. 10010, pp. 2287-2323

  3. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: Quantifying the epidemiological transition

    The Lancet, Vol. 386, Núm. 10009, pp. 2145-2191

  4. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013

    The Lancet, Vol. 386, Núm. 9995, pp. 743-800

  5. Novel mutations associated with nephrogenic diabetes insipidus. A clinical-genetic study

    European Journal of Pediatrics, Vol. 174, Núm. 10, pp. 1373-1385

2014

  1. Health related quality of life measure in systemic pediatric rheumatic diseases and its translation to different languages: An international collaboration

    Pediatric Rheumatology, Vol. 12, Núm. 1

  2. Results from a multicentre international registry of Familial Mediterranean fever: Impact of environment on the expression of a monogenic disease in children

    Annals of the Rheumatic Diseases, Vol. 73, Núm. 4, pp. 662-667

2013

  1. Treatment of autoinflammatory diseases: Results from the Eurofever Registry and a literature review

    Annals of the Rheumatic Diseases, Vol. 72, Núm. 5, pp. 678-685

2010

  1. Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study

    Leukemia Research, Vol. 34, Núm. 9, pp. 1143-1150